Ticker | Sector | Title | Securities Owned | Date Last Transaction | ||
---|---|---|---|---|---|---|
ATNM | Pharmaceutical Preparations | CTO | 560 | 2015-05-07 | ||
SLS | Pharmaceutical Preparations | SVP, Chief Development Officer | 309,628 | 2025-01-10 |
Transaction Date | Company | Title | Form | Trade Types | Δ Securities | Δ Cash | Owned | |
---|---|---|---|---|---|---|---|---|
2025-01-10 | SLS | SVP, Chief Development Officer | 4 | A | 194,300 | $0 | 309.63K | |
2024-12-04 | SLS | SVP, Chief Development Officer | 4 | J | −8,256 | $9.3K | 115.33K | |
2024-06-10 | SLS | SVP, Chief Development Officer | 3 | 0 | $0 | 118.58K |
Company | Ticker | Date | Ratio |
---|---|---|---|
Actinium Pharmaceuticals, Inc. | ATNM | 2020-08-11 | 1:30 |
SELLAS Life Sciences Group, Inc. | SLS | 2019-11-08 | 1:50 |